SCHEMBL25329155

SCHEMBL25329155

O=S(=O)(O)c1ccc(CCC2(O)CCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.39
LMNA P02545 1/20 0.38
OPRM1 P35372 4/20 0.38
OPRL1 P41146 3/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
NT5E P21589 1/20 0.37
CA2 P00918 5/20 0.36
CA1 P00915 3/20 0.36
CA12 O43570 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA5A P35218 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
OPRD1 P41143 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22260953 0.78 HTR2A (0.40) HTR2ALMNAALDH1A1TSHRNT5E
SCHEMBL13097331 0.77 ESR1 (0.50) LMNAOPRM1OPRL1ALDH1A1CA2
SCHEMBL11583429 0.75 LMNA (0.56) HTR2ALMNAALDH1A1TSHRNT5E
SCHEMBL18047763 0.74 LMNA (0.36) LMNAALDH1A1TSHRNT5ECA2
SCHEMBL10534447 0.74 HPGD (0.38) HTR2ALMNAALDH1A1TSHRCA2
SCHEMBL13097377 0.73 ESR1 (0.50) LMNAOPRM1OPRL1ALDH1A1CA2
SCHEMBL6426986 0.72 LMNA (0.37) LMNAALDH1A1TSHRNT5ECA2
SCHEMBL30446884 0.72 CA2 (0.57) LMNAALDH1A1TSHRNT5ECA2
SCHEMBL5149397 0.72 TAAR1 (0.42) HTR2AOPRM1OPRL1ALDH1A1HSD11B1
SCHEMBL92261 0.70 CA2 (0.67) LMNAALDH1A1TSHRNT5ECA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3644991-B1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2023-08-02 EP disclosed